FibroBiologics, Inc. — Proxy Solicitation & Information Statement 2024

Jul 8, 2024

DEFA14A 1 formdefa14.htm

Field: Rule-Page

Field: /Rule-Page

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

SCHEDULE 14A INFORMATION

Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934

(Amendment No.__)

| Filed
by the Registrant | ☒ |
| --- | --- |
| Filed
by a Party other than the Registrant | ☐ |

Check the appropriate box:

☐	Preliminary Proxy Statement
☐	Confidential, for Use of
the Commission Only (as permitted by Rule 14a-6(e)(2))
☐	Definitive Proxy Statement
☒	Definitive Additional Materials
☐	Soliciting Material under
§ 240.14a-12

| FIBROBIOLOGICS,
INC. |
| --- |
| (Name of Registrant as Specified
In Its Charter) |
| (Name of Person(s) Filing
Proxy Statement if Other Than the Registrant) |

Payment of Filing Fee (Check all boxes that apply)

☒	No fee required.
☐	Fee paid previously with
preliminary materials.
☐	Fee computed on table in
exhibit required by Item 25(b) per Exchange Act Rules 14a-6(i)(1) and 0-11.

Field: Rule-Page

Field: /Rule-Page

Field: Page; Sequence: 1

Field: /Page

Field: Page; Sequence: 2

Field: /Page

Field: Page; Sequence: 3; Options: Last

Field: /Page